Trial NCT04324606 / EudraC
Publication Voysey M, Lancet, 2021
Primary outcome on the report: Symptomatic COVID-19 disease defined as a NAAT+ swab combined with at least one qualifying symptom (fever ? 37.8oC; cough; shortness of breath; anosmia or ageusia)

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.